Lunai Bioworks Inc
(LNAI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -88,426 | -72,694 | -13,704 | -9,175 | -39,684 |
| Depreciation Amortization | 54,954 | 43,197 | 425 | 195 | 19,422 |
| Accounts payable and accrued liabilities | 4,057 | 2,110 | 281 | 124 | 3,895 |
| Other Working Capital | 8,812 | 5,116 | 753 | 597 | 4,305 |
| Other Operating Activity | 9,632 | 13,714 | 6,321 | 5,482 | 287 |
| Operating Cash Flow | $-10,971 | $-8,558 | $-5,924 | $-2,777 | $-11,775 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -70 | -47 | -42 | N/A | -30 |
| Net Acquisitions | 66 | 66 | N/A | N/A | N/A |
| Other Investing Activity | -1,256 | -1,226 | -1,074 | -1,058 | 0 |
| Investing Cash Flow | $-1,260 | $-1,207 | $-1,115 | $-1,058 | $-30 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 8,046 | 5,355 | 3,490 | 750 | N/A |
| Common Stock Issued | 342 | 342 | 2,342 | N/A | 5,637 |
| Other Financing Activity | 2,130 | 2,354 | -422 | 1,813 | -1,122 |
| Financing Cash Flow | $10,518 | $8,051 | $5,410 | $2,563 | $4,515 |
| Exchange Rate Effect | 60 | 152 | -1 | -79 | -8 |
| Beginning Cash Position | 1,875 | 1,875 | 1,875 | 1,875 | 9,172 |
| End Cash Position | 221 | 313 | 244 | 524 | 1,875 |
| Net Cash Flow | $-1,654 | $-1,562 | $-1,631 | $-1,351 | $-7,298 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,971 | -8,558 | -5,924 | -2,777 | -11,775 |
| Capital Expenditure | -70 | -47 | -42 | N/A | -30 |
| Free Cash Flow | -11,042 | -8,605 | -5,965 | -2,777 | -11,804 |